Allan Reine's Net Worth

$967 Thousand

Estimate Recalculated Nov 1, 2024 06:00AM EST

Who is Allan Reine?

Allan Reine does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PIERIS PHARMACEUTICALS, INC., Foghorn Therapeutics Inc., and Prime Medicine, Inc..

SEC CIK

Allan Reine's CIK is 0001714023

Past Insider Trading and Trends

2017 was Allan Reine's most active year for acquiring shares with 3 total transactions. Allan Reine's most active month to acquire stocks was the month of July. 2017 saw Allan Reine paying a total of $313,350.00 for 515,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $15

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
—
—
0
Feb 20
Form 4
∞
65K
$4.82
$313,350.00
65K
Aug 16 - Aug 17
Form 4
—
0
—
—
0
Aug 9
Form 3
—
0
—
—
0
No matching records found

Foghorn Therapeutics Inc. (FHTX) Snapshot price: $7.53

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jan 26
Form 4
+100.00%
26.89K
$3.72
$100,038.24
53.78K
Aug 9
Form 4
—
0
—
—
0
Jan 28
Form 3
—
0
—
—
0
No matching records found

Prime Medicine, Inc. (PRME) Snapshot price: $3.4303

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Jan 17
Form 3
—
0
—
—
0
No matching records found